FindTrial
Sign In

Serum Fetuin Level in Polycystic Ovary Syndrome

Serum Fetuin Level as a Marker in Polycystic Ovary Syndrome

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03819998
Enrollment
50
Registered
2019-01-29
Start date
2019-01-30
Completion date
2020-02-05
Last updated
2019-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic Ovary

Brief summary

polycystic ovary syndrome is a common gynecological problem

Detailed description

Understanding the pathophysiology and the cause is of much importance for proper management of this problem

Interventions

DIAGNOSTIC_TESTmeasurement of Fetuin-A level in serum

Fetuin A level will be measured in blood of the PCOS women

Sponsors

Cairo University
CollaboratorOTHER
National Research Centre, Egypt
CollaboratorOTHER
Aljazeera Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 42 Years
Healthy volunteers
Yes

Inclusion criteria

* women who have PCOS in group 1 and who donnot have PCOS in group 2 with age between 20 -42 years

Exclusion criteria

* women above 42 years old

Design outcomes

Primary

MeasureTime frameDescription
The number of women who will have high level of fetuin A and has PCOSwithin a weekEvaluation of women who have PCOS in relation to fetuin A level

Countries

Egypt

Contacts

Primary ContactMahmoud Alalfy, PhD
mahmoudalalfy@ymail.com01002611058

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026